eLife

eLife is a unique collaboration between funders and practitioners of research to communicate influential discoveries in the life and biomedical sciences in the most effective way. It is launched with support from the Howard Hughes Medical Institute, the Wellcome Trust, and the Max Planck Society in November 2012. eLife represents a new model of scientific publishing, designed to meet the needs of scientists in life sciences and biomedicine in a better way. This includes free, immediate, online access to scientific articles; rapid, fair, and constructive review; and innovation in content presentation – in short, a journal for scientists, run by scientists. Initial decisions are made by eLife’s senior editors, and, if a submission is selected for further assessment, full peer review is overseen by eLife’s 175-member board of reviewing editors. The reviewing editor and reviewers consult once peer review comments are submitted, and provide a consolidated list of instructions to authors – eliminating unnecessary and time-consuming rounds of revision.

Publisher
eLife Sciences Publications, Ltd
Website
http://www.elifesciences.org/

Some content from Wikipedia, licensed under CC BY-SA

Neuroscience

Drug reverses age-related cognitive decline within days

Just a few doses of an experimental drug can reverse age-related declines in memory and mental flexibility in mice, according to a new study by UC San Francisco scientists. The drug, called ISRIB, has already been shown in ...

Oncology & Cancer

Pancreatic cancer cells shown to feed on hyaluronic acid

Hyaluronic acid, or HA, is a known presence in pancreatic tumors, but a new study from researchers at the University of Michigan Health Rogel Cancer Center shows that hyaluronic acid also acts as food to the cancer cells. ...

Medications

Researchers find that aspirin alters colorectal cancer evolution

Cancer starts when cells start dividing uncontrollably. Scientists have known that taking aspirin can help protect against the development of colorectal cancer—cancer afflicting the colon or rectum—but the exact reason ...

Medications

Asthma drug can block crucial SARS-CoV-2 protein

A drug used to treat asthma and allergies can bind to and block a crucial protein produced by the virus SARS-CoV-2, and reduce viral replication in human immune cells, according to a new study by researchers at the Indian ...

page 1 from 30